Slide 1: Full Year Results
Full Year Results 30 June 2025
Slide 2: Agenda
Agenda 1. Strategic Plan & Focus 2. Business Highlights 3. Full Year Results Update 4. Key Strategic Priorities 2
Slide 3: Strategic Plan & Focus
Strategic Plan & Focus ~~
Slide 4: Strategic Plan, Growth Strategy and Unique Competencies
STRATEGIC “A progressive House of Brands, transforming wellness, longevity, and quality of life — PLAN inspiring healthier futures and elevating life at every stage.” GROWTH STRATEGY STRATEGIC UNIQUE ● Grow Oli6® into a full life-stage brand; PRIORITIES COMPETENCIES strengthen positioning to drive p
Slide 5: Business Highlights
Business Highlights ~~
Slide 6: Business Highlights
Business Highlights • Refreshed business strategy, 3-year plan and focus on driving the business to profitability • Group revenue1 of $22.9m up $12.0m or 110% pcp2, reflecting strong sales growth in ANZ Retail, China CBEC and Vietnam for Oli6® Nutritionals3 and a significant uplift delivered by the
Slide 7: Full Year Results Update
Full Year Results Update ~~
Slide 8: FY25 Results Update
FY25 Results Update Sales Revenue1 ($ millions) • Group revenue1 of $22.9m in FY25 up $12.0m or 110% pcp2, 25.0 22.9 reflecting strong sales growth of Oli6® Nutritionals of $3.4m or 31% 20.0 pcp in ANZ Retail, China CBEC and entry into the Vietnamese market 6.4 in H2 FY25 combined with Practitioner
Slide 9: FY25 Adjusted EBITDA
FY25 Adjusted EBITDA $ millions FY25 FY24 Sales revenue1 up $12m or 110% Sales Revenue 22.9 10.9 Oli6® sales revenue in FY25 of $14.3m up $3.4m or 31% pcp2 Cost of sales (excluding raw material sales) (11.9) (7.0) FY25 sales were also boosted by sales in the Practitioner channel, through the Gro
Slide 10: Continued improvement in operating cash outflows
Continued improvement in operating cash outflows Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Adjusted operating cash used in operations 1 reduced by a 22 22 22 22 23 23 23 23 24 24 24 24 25 FY25 25 25 further $0.9m or 27% pcp with the key levers being: 1000 Introduction of Practitioner channel
Slide 11: Balance Sheet
Balance Sheet $ millions 30 Jun 2025 30 Jun 2024 Cash holding of $3.6m Cash and short term deposits 3.6 7.6 Trade and other receivables 3.0 2.2 Closing cash position $3.6m at 30 June 2025, with the reduction from 30 June 2024 Prepayments 0.4 0.5 primarily relating to cash used in operations and on
Slide 12: Key Strategic Priorities
Key Strategic Priorities 12
Slide 13: Key Strategic Priorities
Key Strategic Priorities 1. Global Expansion and Market Relevance: Unlock international potential by: a) Further expanding Oli6® in South-East Asia building on current success in ANZ, China and Vietnam b) Tapping into adjacent categories to broaden Oli6’s health ecosystem 2. Innovation-Led Product D
Slide 14: Disclaimer
Disclaimer • This presentation has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. In particular, this presentation does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States
Slide 15: Appendix
Appendix 15
Slide 16: Appendix 1
Appendix 1 (a) Adjusted EBITDA reconciliation: $ millions FY25 FY24 EBITDA (3.2) (7.3) Impairment of assets 0.0 0.1 Product Obsolescence & provisioning 0.0 0.3 Business combination costs on acquisition 0.0 1.0 Earn Out Payment Linked to Business Acquisition 0.4 0.0 Derecognition of deferred consider
Slide 17: Oli’
Oli’ GOAT MILK Practica